INS and type 2 diabetes mellitus: In summary, estradiol in T2DM promotes insulin secretion, inhibits glucagon release and hepatic gluconeogenesis, promotes pancreatic β-cell survival, stimulates energy expenditure and food intake, and promotes glucose uptake in muscle and adipocytes.